Viewpoint

All That Glitters

With respect for the evidence that randomized clinical trials afford, their value is inflated in many ways. And their authority is always worth questioning.

...more
Viewpoint

Science, Fast and Slow

From CRISPR to AI, new technologies progress quickly. The regulation of science needs to be taken seriously from the very start.

...more
Viewpoint

Audiences

The diversity of audiences that we face in science push us to consider and reconsider how we present our work.

...more
Viewpoint

Authority

As scientists, our authority is always fleeting. And this is how it should be.

...more
Viewpoint

Diversifying Science

The problems of diversity in science run deeper than identity. We also need diversity of perspectives.

...more
1 2 3 4
SHARES